“Prevalence of persistent hypogammaglobulinemia in patients with autoimmune disease receiving rituximab at a national referral center in Mexico”, Rev Alerg Mex, vol. 69, no. 4, pp. 171–182, Apr. 2023, doi: 10.29262/ram.v69i4.1142.